Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
Learn more about:
Related Clinical Trial
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses and Repeat Doses of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch